(Q84953850)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22961630%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22961630%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

main subject

hepatocellular carcinoma

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22961630%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Junliang Fu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22961630%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Zheng Zhang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22961630%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Lin Zhou

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22961630%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Zhaorui Qi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22961630%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Jiyun Lv

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22961630%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Jianfei Shi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22961630%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Baoyun Fu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22961630%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Zhenwen Liu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22961630%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Ji-Yuan Zhang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22961630%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Lei Jin

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22961630%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Yulai Zhao

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22961630%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

George K K Lau

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22961630%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Jingmin Zhao

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22961630%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Fu-Sheng Wang

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22961630%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

15 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22961630%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22961630%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22961630%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22961630%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

139-149

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22961630%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

cites work

Hepatocellular carcinoma

1 reference

7 January 2021

Twenty-year trends of primary liver cancer incidence rates in an urban Chinese population

1 reference

7 January 2021

The physiological role of cytotoxic CD4(+) T-cells: the holy grail?

1 reference

7 January 2021

Cytotoxic human CD4(+) T cells

1 reference

7 January 2021

Characterization of CD4(+) CTLs ex vivo

1 reference

7 January 2021

Cytolytic CD4(+) T cells in viral immunity

1 reference

7 January 2021

Virus-specific CD4+ T cells: ready for direct attack

1 reference

7 January 2021

Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy

1 reference

7 January 2021

Human cytotoxic CD4+ T cells recognize HLA-DR1-restricted epitopes on vaccinia virus proteins A24R and D1R conserved among poxviruses

1 reference

7 January 2021

Cytotoxic CD4+ T cells use granulysin to kill Cryptococcus neoformans, and activation of this pathway is defective in HIV patients

1 reference

7 January 2021

Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts

1 reference

7 January 2021

Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma.

1 reference

7 January 2021

Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection

1 reference

7 January 2021

Cytotoxic CD4 T cells in viral hepatitis

1 reference

7 January 2021

Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection.

1 reference

7 January 2021

Functional subsets of CD4 T cells in rheumatoid synovitis

1 reference

7 January 2021

Prevalence, clinical relevance and characterization of circulating cytotoxic CD4+CD28- T cells in ankylosing spondylitis

1 reference

7 January 2021

Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL)

1 reference

7 January 2021

Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.

1 reference

7 January 2021

Management of hepatocellular carcinoma: An update

1 reference

7 January 2021

Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients

1 reference

7 January 2021

Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B

1 reference

7 January 2021

Induction of primary anti-HIV CD4 and CD8 T cell responses by dendritic cells transduced with self-inactivating lentiviral vectors

1 reference

7 January 2021

Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation

1 reference

7 January 2021

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

1 reference

7 January 2021

CD4 cells can be more efficient at tumor rejection than CD8 cells

1 reference

7 January 2021

Role of cytotoxic CD4+ T cells in cancer immunotherapy

1 reference

7 January 2021

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

1 reference

7 January 2021

Cancer immunotherapy--the endgame begins

1 reference

7 January 2021

Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients

1 reference

7 January 2021

Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells

1 reference

7 January 2021

CD4+CD28null T cells in autoimmune disease: pathogenic features and decreased susceptibility to immunoregulation.

1 reference

7 January 2021

Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients.

1 reference

7 January 2021

Cancer-related inflammation

1 reference

7 January 2021

Immunity, Inflammation, and Cancer

1 reference

7 January 2021

Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

1 reference

7 January 2021

Feedback regulation of pathogen-specific T cell priming.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.26054

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22961630%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference